Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aschermann

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Casopis Lekaru Ceskych|November 25, 2003
[Comparison of the morphology of atherosclerotic plaques in patients with stable angina pectoris and acute coronary syndrome using intravascular ultrasonography]T Kovárník, V Reznícek, K Novácková, et al.
Casopis Lekaru Ceskych|March 29, 2003
[Interventional therapy of the inferior vena cava syndrome]S Jirát, P Varejka, M Chochola, et al.
Bratislavske Lekarske Listy|October 21, 2006
Initial experiences with novel therapy for pulmonary hypertension in SlovakiaI Simkova, J Pacak, I Riecansky, et al.
Bratislavske Lekarske Listy|March 10, 2011
Effect of warfarin anticoagulation on thrombin generation in patients with idiopathic pulmonary arterial hypertensionP Jansa, I Hrachovinova, D Ambroz, et al.
Casopis Lekaru Ceskych|July 29, 2005
[Takotsubo cardiomyopathy: case report and literature review]T Palecek, A Linhart, P Jansa, et al.
Journal of Inherited Metabolic Disease|January 5, 2002
Cardiac manifestations in Fabry diseaseA Linhart, J C Lubanda, T Palecek, et al.
Cardiovascular Drugs and Therapy|May 18, 2011
Reduced thrombin generation and soluble P-selectin after intravenous enoxaparin during PCIJ Kvasnička, J Horák, Z Zenáhlíková, et al.
Vnitrni Lekarstvi|July 28, 1999
[Treatment of significant coronary stenoses using stents without preliminary balloon angioplasty: present status, results, perspectives]J Veselka, D Tesar, M Mates, et al.
Vnitrni Lekarstvi|November 12, 2002
[Is mild essential hypertension without obvious organ complications and risk factors associated with increased levels of circulating markers of endothelial dysfunction? Effect of ACE inhibitor therapy]Z Hlubocká, V Umnerová, S Heller, et al.
Bratislavske Lekarske Listy|March 3, 2020
Predictors of survival in patients with pulmonary hypertension and acute right heart failureD Ambroz, P Jansa, J Kuchar, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Casopis Lekaru Ceskych|November 25, 2003
[Comparison of the morphology of atherosclerotic plaques in patients with stable angina pectoris and acute coronary syndrome using intravascular ultrasonography]T Kovárník, V Reznícek, K Novácková, et al.
Casopis Lekaru Ceskych|March 29, 2003
[Interventional therapy of the inferior vena cava syndrome]S Jirát, P Varejka, M Chochola, et al.
Bratislavske Lekarske Listy|October 21, 2006
Initial experiences with novel therapy for pulmonary hypertension in SlovakiaI Simkova, J Pacak, I Riecansky, et al.
Bratislavske Lekarske Listy|March 10, 2011
Effect of warfarin anticoagulation on thrombin generation in patients with idiopathic pulmonary arterial hypertensionP Jansa, I Hrachovinova, D Ambroz, et al.
Casopis Lekaru Ceskych|July 29, 2005
[Takotsubo cardiomyopathy: case report and literature review]T Palecek, A Linhart, P Jansa, et al.
Journal of Inherited Metabolic Disease|January 5, 2002
Cardiac manifestations in Fabry diseaseA Linhart, J C Lubanda, T Palecek, et al.
Cardiovascular Drugs and Therapy|May 18, 2011
Reduced thrombin generation and soluble P-selectin after intravenous enoxaparin during PCIJ Kvasnička, J Horák, Z Zenáhlíková, et al.
Vnitrni Lekarstvi|July 28, 1999
[Treatment of significant coronary stenoses using stents without preliminary balloon angioplasty: present status, results, perspectives]J Veselka, D Tesar, M Mates, et al.
Vnitrni Lekarstvi|November 12, 2002
[Is mild essential hypertension without obvious organ complications and risk factors associated with increased levels of circulating markers of endothelial dysfunction? Effect of ACE inhibitor therapy]Z Hlubocká, V Umnerová, S Heller, et al.
Bratislavske Lekarske Listy|March 3, 2020
Predictors of survival in patients with pulmonary hypertension and acute right heart failureD Ambroz, P Jansa, J Kuchar, et al.
Pageof 15